Logo image of ILMN

ILLUMINA INC (ILMN) Stock Price, Quote, News and Overview

NASDAQ:ILMN - Nasdaq - US4523271090 - Common Stock - Currency: USD

75.76  -3.82 (-4.8%)

After market: 76 +0.24 (+0.32%)

ILMN Quote, Performance and Key Statistics

ILLUMINA INC

NASDAQ:ILMN (5/9/2025, 8:00:52 PM)

After market: 76 +0.24 (+0.32%)

75.76

-3.82 (-4.8%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High156.66
52 Week Low68.7
Market Cap11.99B
Shares158.26M
Float157.95M
Yearly DividendN/A
Dividend YieldN/A
PE22.75
Fwd PE14.73
Earnings (Next)08-04 2025-08-04/amc
IPO06-28 2000-06-28


ILMN short term performance overview.The bars show the price performance of ILMN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

ILMN long term performance overview.The bars show the price performance of ILMN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of ILMN is 75.76 USD. In the past month the price increased by 6.31%. In the past year, price decreased by -31.46%.

ILLUMINA INC / ILMN Daily stock chart

ILMN Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 18.41 152.18B
DHR DANAHER CORP 25.47 135.78B
A AGILENT TECHNOLOGIES INC 20.14 30.49B
IQV IQVIA HOLDINGS INC 13.18 26.27B
MTD METTLER-TOLEDO INTERNATIONAL 26.72 22.53B
WAT WATERS CORP 28.89 20.47B
WST WEST PHARMACEUTICAL SERVICES 32.09 15.31B
ICLR ICON PLC 9.76 11.06B
RVTY REVVITY INC 18.51 10.96B
TEM TEMPUS AI INC N/A 10.62B
QGEN QIAGEN N.V. 18.2 9.05B
MEDP MEDPACE HOLDINGS INC 22.6 8.51B

About ILMN

Company Profile

ILMN logo image Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,970 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.

Company Info

ILLUMINA INC

5200 Illumina Way

San Diego CALIFORNIA 92122 US

CEO: Francis A. deSouza

Employees: 8970

ILMN Company Website

ILMN Investor Relations

Phone: 18582024500

ILLUMINA INC / ILMN FAQ

What is the stock price of ILLUMINA INC today?

The current stock price of ILMN is 75.76 USD. The price decreased by -4.8% in the last trading session.


What is the ticker symbol for ILLUMINA INC stock?

The exchange symbol of ILLUMINA INC is ILMN and it is listed on the Nasdaq exchange.


On which exchange is ILMN stock listed?

ILMN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ILLUMINA INC stock?

31 analysts have analysed ILMN and the average price target is 116.42 USD. This implies a price increase of 53.67% is expected in the next year compared to the current price of 75.76. Check the ILLUMINA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ILLUMINA INC worth?

ILLUMINA INC (ILMN) has a market capitalization of 11.99B USD. This makes ILMN a Large Cap stock.


How many employees does ILLUMINA INC have?

ILLUMINA INC (ILMN) currently has 8970 employees.


What are the support and resistance levels for ILLUMINA INC (ILMN) stock?

ILLUMINA INC (ILMN) has a support level at 75.2 and a resistance level at 75.87. Check the full technical report for a detailed analysis of ILMN support and resistance levels.


Is ILLUMINA INC (ILMN) expected to grow?

The Revenue of ILLUMINA INC (ILMN) is expected to decline by -0.88% in the next year. Check the estimates tab for more information on the ILMN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ILLUMINA INC (ILMN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ILLUMINA INC (ILMN) stock pay dividends?

ILMN does not pay a dividend.


When does ILLUMINA INC (ILMN) report earnings?

ILLUMINA INC (ILMN) will report earnings on 2025-08-04, after the market close.


What is the Price/Earnings (PE) ratio of ILLUMINA INC (ILMN)?

The PE ratio for ILLUMINA INC (ILMN) is 22.75. This is based on the reported non-GAAP earnings per share of 3.33 and the current share price of 75.76 USD. Check the full fundamental report for a full analysis of the valuation metrics for ILMN.


What is the Short Interest ratio of ILLUMINA INC (ILMN) stock?

The outstanding short interest for ILLUMINA INC (ILMN) is 3.48% of its float. Check the ownership tab for more information on the ILMN short interest.


ILMN Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to ILMN. When comparing the yearly performance of all stocks, ILMN is a bad performer in the overall market: 86.19% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ILMN Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to ILMN. Both the profitability and the financial health of ILMN get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ILMN Financial Highlights

Over the last trailing twelve months ILMN reported a non-GAAP Earnings per Share(EPS) of 3.33. The EPS increased by 278.41% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -19.39%
ROE -51.5%
Debt/Equity 0.63
Chartmill High Growth Momentum
EPS Q2Q%977.78%
Sales Q2Q%-3.25%
EPS 1Y (TTM)278.41%
Revenue 1Y (TTM)-2.93%

ILMN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 74% to ILMN. The Buy consensus is the average rating of analysts ratings from 31 analysts.

For the next year, analysts expect an EPS growth of 85.5% and a revenue growth -0.88% for ILMN


Ownership
Inst Owners104.43%
Ins Owners0.14%
Short Float %3.48%
Short Ratio2.14
Analysts
Analysts73.55
Price Target116.42 (53.67%)
EPS Next Y85.5%
Revenue Next Year-0.88%